# Epicare Acquisitions, Llc – FDA Inspection, Dec 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/epicare-acquisitions-llc/5c8e6a9b-6b08-4436-8941-9a8a3afc753a
Source feed: FDA_Inspections

> FDA inspection 1256450 of Epicare Acquisitions, Llc, December 13, 2024. Classification: Official Action Indicated (OAI). 10 citations under 21 CFR parts 801, 820, 830 and 1010. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256450
- Company Name: Epicare Acquisitions, Llc
- Inspection Date: 2024-12-13
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: New Jersey District Office
- Citation Count: 10

## Related Documents

- [FDA Inspection 1298218 - 2026-01-12](https://www.keypedia.com/records/fda_inspections/epicare-acquisitions-llc/d655ea4d-2ce8-49cb-8e2e-9dfc077718e5)
- [FDA Inspection 1161983 - 2022-02-10](https://www.keypedia.com/records/fda_inspections/epicare-acquisitions-llc/655ac347-30a1-4a4a-891a-48deeb2237f0)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/william-r-chang/67893bac-29e2-45b4-ba2c-1ef548781b9c)

Company: https://www.keypedia.com/companies/epicare-acquisitions-llc/00ff358c-1f18-422c-bdfb-b620f91674f6

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
